Related by context. Frequent words. (Click for all words.) 68 Corp. TSX BVF 64 NYSE BVF 64 Biovail Corp 58 Axcan Pharma 58 CMVT.PK 58 PROFILE CO 58 Bearish Pressure Building 57 Inc. PFE.N Quote 56 Calls Purchased 56 founder Eugene Melnyk 56 Cardiome Pharma Corp. 55 Co. MRK.N Quote 55 quotes/comstock/# * 55 Inc. AL.TO Quote 55 Inc.รข 55 Bristol Myers Squibb BMY.N 54 Axcan Pharma Inc. 54 Company Nasdaq PRGO 54 FY# Q3 earnings 53 Biotech drugmaker 53 Declares Quarterly Dividends 53 antidepressant Wellbutrin XL 53 Q4 Loss Widens 53 TSX QLT 53 Q4 Loss Narrows 53 Teva Pharmaceutical TEVA 52 & Co MRK.N 52 Biovail 52 Acadia Pharmaceuticals 52 Q2 Profit Surges 52 Natural Resources CNQ.TO Quote 52 Lorus Therapeutics 52 Suncor Energy SU.TO Quote 52 volatility Elevated 52 Inc. FY# Q3 52 Cardiome Pharma 52 Bullish Pressure 52 Paladin Labs 51 YM BioSciences Inc. 51 Q2 Loss Narrows 51 Nasdaq BIIB 51 Vicuron Pharmaceuticals 51 Q3 Loss Widens 51 Co. Initiates Independent 51 Q3 Loss Narrows 51 Schering Plough NYSE SGP 51 Co Inc MRK.N 51 NYSE PFE 51 Welcomes Analyst 50 Ariad Pharmaceuticals Inc. 50 Aspreva Pharmaceuticals 50 CIBC CM 50 NYSE SGP 50 Corp. GENZ 50 Threshold Pharmaceuticals 50 Bayer AG BAY GY 50 experimental hepatitis C 50 Par Pharmaceuticals 50 CEO Exercises Options 50 TSX MDS 50 Transkaryotic Therapies Inc. 50 Webcast Annual Meeting 50 Transition Therapeutics 50 Earnings Scorecard 50 Genelabs Technologies Inc. 50 SXDP 50 MNTA 50 Barrick Gold ABX.TO Quote 49 Q2 Loss Widens 49 OPTR 49 Barrier Therapeutics Inc. 49 Transition Therapeutics Inc. 49 Allergan AGN 49 Mylan Labs 49 TSX RCI 49 Director Exercises Options 49 Buyers Accumulating Shares 49 Quote Quote 49 Cephalon CEPH 49 Posts Wider Loss 49 Tekmira Pharmaceuticals Corporation 49 CFO resigns 49 FY# Q4 49 Q1 Loss Narrows 49 Movers Roundup 49 SEPR 49 Ariad Pharmaceuticals 49 Actelion Ltd 49 Vanda Pharmaceuticals Inc. 49 percentage decliner 49 Enzo Biochem 48 Liponex 48 PERCENT TO 48 AUXL 48 Dimethaid 48 CryoCath Technologies Inc. 48 Pfizer Inc PFE.N 48 Movers roundup 48 FY# Q2 48 Somaxon Pharmaceuticals 48 Paladin Labs Inc.